IDEAYA Biosciences, Inc. IDYA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$98.54M-36.5% | -$83.27M+36.1% | $119.24M+330% | -$77.49M-46.8% | -$72.18M-82.4% | ||
| $688K+14.7% | $721K+26.0% | $661K+14.6% | $718K+15.4% | $600K-2.6% | ||
| $14.54M+42.0% | $11.79M+24.3% | $12.22M+32.6% | $11.87M+21.9% | $10.24M+62.2% | ||
| —— | -$0+100% | -$0-100% | -$0+100% | -$0+100% | ||
| $3.05M+11.8% | —— | $1.19M— | —— | $2.73M+702% | ||
| $2.73M-5.1% | —— | $7.51M+159% | $4.84M-29.8% | $2.88M+326% | ||
| -$3.03M-254% | $5.56M+224% | $0-100% | $500K+40.1% | $1.97M-37.1% | ||
| -$587K— | —— | —— | —— | $0— | ||
| $455K-14.6% | $476K+570% | $369K-15.2% | $515K+8.4% | $533K+14.4% | ||
| -$75.17M-24.6% | -$90.5M+25.6% | $142.21M+389% | -$62.47M-90.0% | -$60.34M-37.7% | ||
| $967K-27.3% | $333K-69.8% | $42K-90.8% | $663K-31.9% | $1.33M+0.4% | ||
| $42.61M-59.5% | $236.14M-29.9% | $138.99M-35.0% | $127.55M-22.6% | $105.21M-77.9% | ||
| $162.53M-12.8% | $138.95M-1.5% | $180.8M-6.9% | $174.13M-25.7% | $186.35M+51.3% | ||
| $118.95M+49.0% | —— | $41.77M+308% | $45.92M— | $79.82M+123% | ||
| $1.19M+4.9% | -$1.93M— | $384K-99.9% | $410K+100% | $1.13M-99.7% | ||
| $1.18M-95.5% | $2.13M-22.6% | $301K-99.9% | $1.21M-96.9% | $26.14M-92.5% | ||
| $44.96M-1.4% | —— | $184.28M-15.2% | —— | $45.62M+194% | ||
| —— | $0— | $0-100% | $0-100% | $0-100% | ||
| $1.21M-67.9% | $1.52M-69.0% | $1.98M-63.0% | $2.69M-59.5% | $3.78M-40.2% | ||
| $2.73M-5.1% | —— | $7.51M+159% | $4.84M-29.8% | $2.88M+326% | ||
| —— | $1.49M— | $1.49M— | $1.49M— | $1.49M— | ||
| $686K+12.3% | $669K+878% | $648K+331% | $629K+217% | $611K+231% | ||
| -$3.03M-254% | $5.56M+224% | $0-100% | $500K+40.1% | $1.97M-37.1% | ||
| $455K-14.6% | $476K+570% | $369K-15.2% | $515K+8.4% | $533K+14.4% | ||
| $162.53M-12.8% | $138.95M-1.5% | $180.8M-6.9% | $174.13M-25.7% | $186.35M+51.3% | ||
| -$9K-100% | —— | —— | —— | $25.01M— | ||
| $1.2M+83.6% | $433K+115% | $0-100% | $3K— | $654K+257% | ||
| —— | $0— | $0-100% | $0— | $0— | ||
| $0-100% | —— | —— | —— | $6.19M— | ||
| $98K— | —— | —— | —— | $0— | ||
| -$76.14M-23.5% | -$90.83M+26.0% | $142.17M+386% | -$63.14M-86.5% | -$61.67M-36.6% | ||
| -$76.14M-23.5% | -$90.83M+26.0% | $142.17M+386% | -$63.14M-86.5% | -$61.67M-36.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does IDEAYA Biosciences, Inc. generate?
- IDEAYA Biosciences, Inc. (IDYA) generated -$85.9M in operating cash flow over the trailing twelve months.
- What is IDEAYA Biosciences, Inc.'s free cash flow?
- After $2.0M of capital expenditures, IDEAYA Biosciences, Inc.'s free cash flow was -$87.9M over the trailing twelve months, up 67.2% year over year.
- Where does IDEAYA Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from IDEAYA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
